It is a pharma private limited company based in New Delhi, Delhi, India, established in 2015.
2015 | New Delhi, Delhi, India | ActiveCure Quick Pharma Private Limited, a active private limited company, was established on 09 November 2015 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24100DL2015PTC287272. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹4.00 M and a paid-up capital of ₹3.80 M.
It upholds a compliant status. Its leadership includes Siddharth (Director), Harish Kumar Digani (Director). Past directors included Rajesh Kumar. It holds ₹8.80 Cr open charges and no settled loans. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at House No. 38, Sfs Flats, Block-Bu Pitampura, New Delhi, Delhi, 110034.
U24100DL2015PTC287272
287272
09 November 2015
₹4.00 M
₹3.80 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Cure Quick Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Siddharth | Director | 18 Jan 2024 | Current |
| Harish Kumar Digani | Director | 09 Nov 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 19 Jan 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cure Quick Pharma Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 64.86% decrease. The company also saw a substantial fall in profitability, with a 129.46% decrease in profit. The company's net worth dipped by a decrease of 1.14%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Cure Quick Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹88,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jun 2020 | State Bank Of India | ₹8.80 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Cure Quick Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Cure Quick Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cure Quick Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Siddharth was appointed as a Director was appointed as a Director on 18 Jan 2024 & has been associated with this company since 1 year 10 months . was completed.
Cure Quick Pharma Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was recorded as a recent event.
The activity Cure Quick Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Delhi. was completed.
The activity A charge with State Bank Of India amounted to Rs. 88.00 M with Charge ID 100349053 was registered on 24 Jun 2020. was completed.
The activity Harish Kumar Digani was appointed as a Director was appointed as a Director on 09 Nov 2015 & has been associated with this company since 10 years 23 days . was completed.
Cure Quick Pharma Private Limited was registered on 09 Nov 2015 with Roc Delhi & aged 10 years 23 days as per MCA records. was recorded as a recent event.
The CIN of Cure Quick Pharma Private Limited is U24100DL2015PTC287272.
Cure Quick Pharma Private Limited is headquartered at House No. 38, Sfs Flats, Block-Bu Pitampura, New Delhi, Delhi, 110034.
Cure Quick Pharma Private Limited was incorporated on 09 November 2015.
The current directors of Cure Quick Pharma Private Limited are
The primary industry of Cure Quick Pharma Private Limited is Manufacturing.
Cure Quick Pharma Private Limited is unlisted.
The authorized capital of Cure Quick Pharma Private Limited is ₹4.00 M, and the paid-up capital is ₹3.80 M.
The compliance status of Cure Quick Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX